Therapeutic delivery and medical device materials are needed to prevent severe complications such as thrombosis, inflammation, and infection for cardiovascular, pulmonary, diabetes, and dental related patient care. Brisbois is intent on finding a better way. Her research focuses on the design and development of novel therapeutics and medical device materials using molecules that exist in our bodies to enhance compatibility and reduce complication.
Education
Ph.D., Chemistry, University of Michigan, 2014
M.S., Chemistry, University of Michigan, 2010
B.S., Chemistry, Concordia University, Seward, NE, 2008
B.S.Ed., Secondary Education, Concordia University, Seward, NE, 2008
Honors / Awards / Achievements
JDRF/FDA Workshop Invited Speaker (1 of 10 invited from U.S.), 2021
UCF College of Engineering & Computer Science Dean’s ADI Award, 2019
Baxter Young Investigator Award (Baxter, Inc.), 2016
National Institute of Health Postdoctoral Fellowship (NRSA F32), 2015
MICHR PTSP Career Development Award, 2015
University of Michigan-Chemistry Research Excellence Fellowship, 2014
Society for Biomaterials STAR Award, 2014
Educational Activities
Antimicrobial and Hemocompatible Interfaces
Anti-inflammatory Biomaterials
Clinical Translational Research
Insulin Delivery
Polymer and Small Molecule Chemistry
Pulmonary and Dental Therapeutics
Tissue Engineering and Biomaterials
Scholarship & Research
Assistant Professor, University of Georgia College of Engineering, School of Chemical, Materials & Biomedical Engineering, 2020 – present
Assistant Professor, University of Central Florida, Department of Materials Science & Engineering, 2017-2020
NIH Postdoctoral Fellow, Department of Surgery, University of Michigan Medical Center, Ann Arbor, MI, 2014-2017
